fda compounding semaglutide enforcement news november 2025 FDA's GLP-1 decision kicks off 'unprecedented' tussle over shortage Buying semaglutide online? Here's what

For others, it represents unnecessary overhead when they already understand proper retatrutide dosing protocols and have the technical knowledge to handle reconstitution independently

The TRIUMPH-4 data reveal that nearly 1 in 4 patients on the highest dose lost 35% of body weight, not just the average ~28.7%

FDA Control Over Salt Forms Versus Base Ingredient The FDA has made clear that the active ingredient in approved medications such as Wegovy and Ozempic is semaglutide in its base form

Namely: No longer covering GLP-1s for weight loss : Several insurers have made the choice to stop providing coverage for these drugs when used specifically for weight loss, while still covering them for other uses like diabetes

Journal of Clinical Endocrinology & Metabolism, 2008

Future research will define how to optimally use retatrutide alone or in combination with other therapies